Search results
Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Zacks via Yahoo News· 1 month agoAlnylam (ALNY) soars as its phase III study, seeking to expand Anvuttra's label to include the...
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Zacks via Yahoo News· 1 month agoIt was a busy week for the biotech sector with quite a few important pipeline and regulatory...
Will Alnylam Pharmaceuticals (ALNY) Report Negative Q2 Earnings? What You Should Know
Zacks via Yahoo News· 1 year agoAlnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely...
Alnylam Pharmaceuticals (ALNY) Reports Q4 Loss, Tops Revenue Estimates
Zacks via Yahoo News· 1 year agoAlnylam (ALNY) delivered earnings and revenue surprises of 21.13% and 9.37%, respectively, for the...
Alnylam (ALNY) Q1 Earnings Beat, Product Sales Drive Revenues
Zacks via Yahoo News· 1 year agoAlnylam Pharmaceuticals (ALNY) reports better-than-expected first-quarter 2023 results. Givlaari,...
Here's Why You Should Add Alnylam (ALNY) Stock to Your Portfolio
Zacks via Yahoo News· 1 year agoAlnylam's (ALNY) revenues continue to be driven by Amvuttra and Givlaari sales. Its existing...
Alnylam (ALNY) Posts Preliminary Q4 & Full-Year '23 Revenues
Zacks via Yahoo News· 7 months agoAlnylam Pharmaceuticals ALNY reported preliminary full-year 2023 net product revenues of $1.24...